Biomerica (BMRA) Debt to Equity (2011 - 2012)
Biomerica recorded quarterly Debt to Equity of $0.01 in Q2 2012, up 242.23% quarter-over-quarter from $0.0 in Q4 2011, and up 5.68% year-over-year from $0.01 in Q2 2011.
Biomerica's Debt to Equity history runs 2 years deep, the most recent figure standing at $0.01 for Q2 2012.
- In Q2 2012, Debt to Equity rose 5.68% year-over-year to $0.01; the TTM figure through May 2012 stood at $0.01 (up 5.68% YoY), while the FY2012 annual figure was $0.01, up 5.68% from the prior year.
- Debt to Equity came in at $0.01 for Q2 2012 at Biomerica, up from $0.0 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $0.01 in Q2 2012 to a low of $0.0 in Q4 2011.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.65 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.64 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.57 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.42 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.06 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.95 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.27 |
| 10 | Biomerica | 7.12 Mn | 5.78 Mn | -44,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2012 | 0.01 |
| Nov 30, 2011 | 0.00 |
| Aug 31, 2011 | 0.01 |
| May 31, 2011 | 0.01 |